Frederick National Laboratory: Vaccine Set for Wider Use Against Mosquito-Borne Chikungunya
March 27, 2026
March 27, 2026
FREDERICK, Maryland, March 27 -- The National Institutes of Health's National Laboratory for Cancer Research issued the following news:
* * *
Vaccine set for wider use against mosquito-borne chikungunya
By Frank Blanchard
An FDA-approved chikungunya vaccine manufactured by the Frederick National Laboratory and tested in early clinical trials a decade ago may become a bigger player in global health following a series of adverse event report . . .
* * *
Vaccine set for wider use against mosquito-borne chikungunya
By Frank Blanchard
An FDA-approved chikungunya vaccine manufactured by the Frederick National Laboratory and tested in early clinical trials a decade ago may become a bigger player in global health following a series of adverse event report . . .